MYRRH HECTOR: Open Payments
NPI 1912691544 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 27 payments from 10 companies in 2025. Trend: 2023 $108 · 2024 $358 · 2025 $542
Food & beverage: $542
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $171 |
| Exact Sciences Corporation | 5 | $84 |
| Novo Nordisk Inc | 3 | $55 |
| Amgen Inc. | 3 | $50 |
| PFIZER INC. | 3 | $48 |
| Lilly USA, LLC | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: AIRSUPRA, Cologuard Collection Kit, BREZTRI, Ozempic, MOUNJARO, PREVNAR 20, TZIELD, XIFAXAN.
Industry payments across AR — which companies pay providers there.
